KEWAUNEE SCIENTIFIC Business Summary

Kewaunee Scientific Corporation (KEQU) operates a vertically integrated business model centered on the design, manufacture, and installation of specialized laboratory, healthcare, and technical furniture. The company generates revenue through transactional sales and long-term contracts for products including steel and wood casework, fume hoods, biological safety cabinets, and adaptable modular systems. Its operations are divided into two primary segments: Domestic, which serves the United States market and was significantly bolstered by the November 2024 acquisition of biosafety leader NuAire, Inc., and International, which manages subsidiaries and manufacturing facilities in India and Singapore to serve the Asian and Middle Eastern markets. Kewaunee competes directly with Labconco, Thermo Fisher Scientific, and Hamilton Laboratory Solutions, maintaining a dominant position as a legacy global leader in the high-end laboratory infrastructure niche, particularly within the education, pharmaceutical, and healthcare sectors. Originally founded in 1906 as a reorganization of a 1903 manufacturing venture, Kewaunee is currently led by President and CEO Thomas D. Hull III, who previously held senior finance roles at ATI Specialty Materials and Ernst & Young. The executive team includes Donald T. Gardner III as Vice President of Finance and CFO, and B. Sathyamurthy, who oversees the International Group. The company’s governance is anchored by a seasoned Board of Directors, including Chairman David S. Rhind and long-standing director Margaret B. Pyle of The Pyle Group. Recent strategic additions to the board include J. Jette Campbell, a partner at Carl Marks Advisors with deep expertise in industrial restructuring, reflecting the company's 2026 focus on inorganic growth and operational scaling following its successful integration of the NuAire acquisition.